Refine your search
Collections
Co-Authors
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Joseph, Dhanish
- The Myth and The fact on Naringin–A Review
Abstract Views :151 |
PDF Views:0
Authors
Affiliations
1 School of Advanced Sciences, VIT, Vellore, IN
1 School of Advanced Sciences, VIT, Vellore, IN
Source
Research Journal of Pharmacy and Technology, Vol 12, No 1 (2019), Pagination: 367-374Abstract
Naringin and naringenin are the two common flavonoids present in the citrus fruits especially in grapefruit. Both this does wonderful functions in human body. It is being contraindicated with many of the drug products due to extensive variation in the kinetics of drugs when both dug and this flavonoid administered together. Thus all the doctors counsel the patients not to have grape fruit with many of the drugs. The common people or the patients are much worried in taking the citrus fruit even after completion of the treatment because of certain myth behind this. The current study aims to reveal the reality behind this caption. The review conducted confirms various proven therapeutic activities of naringin and naringenin as a supplement and certain synergistic effects. It is proven that the consumption of either grape fruit or as naringin or naringenin itself keeps the body healthy away from various illnesses. And it is highly active against various major life style disorders and even as an anti-neoplastic agent.Keywords
Naringin, Hyperlipidemia, Antineoplastic, DNA Repair, Anti-inflammatory, Bone Marrow Protective.References
- Cook NC, Samman S. Flavonoids—chemistry, metabolism, cardioprotective effects, and dietary sources. J NutrBiochem.1996; 7 (2): 66-76.
- Croft KD. The chemistry and biological effects of flavonoids and phenolic acids. AcadSci. 1998; 854: 435-2.
- Peterson J, Dwyer J. Flavonoids: dietary occurrence and biochemical activity. NutrRes . 1998; 18 (12): 1995-2018.
- Fuhr U. Inhibitory Effect of Grapefruit Juice and Its Bitter Principal, Naringenin, on CYP1A2 Dependent Metabolism of Caffeine in Man. Br J ClinPharmacol. 1993; 35 (4) 431-6.
- Nijveldt, RJ. Flavonoids: A Review of Probable Mechanisms of Action and Potential Applications. Am J ClinNutr. 2001;74 (4): 418-5.
- Sugiura M, Ohshima M, Ogawa K, Yano M. Chronic administration of Satsuma mandarin fruit (Citrus unshiu Marc.) improves oxidative stress in streptozotocin-induced diabetic rat liver. Biol Pharm Bull.2006; 29: 588-91.
- Renugadevi J, Prabu SM. Naringenin protects against cadmium-induced oxidative renal dysfunction in rats. Toxicology. 2009; 256(1-2):128-4.
- Jung UJ, Kim HJ, Lee JS, Lee MK, Kim HO, Park EJ, et al. Naringin supplementation lowers plasma lipids and enhances erythrocyte antioxidant enzyme activities in hypercholesterolemic subjects. ClinNutr.2003; 22(6): 561-8.
- Choudhury R, Chowrimootoo G, Srai K, Debnam E, Rice-Evans CA. Interactions of the flavonoid naringenin in the gastrointestinal tract and the influence of glycosylation. BiochimBiophys Res Commun. 1999; 265 (2):410-5.
- Bear WL, and Teel RW. Effects of Citrus Flavonoids on the Mutagenicity of Heterocyclic Amines and on Cytochrome P450 1A2 Activity. Anticancer Res.2000; 20 (5b): 3609-14.
- Ho PC, Saville DJ, Wanwimolruk S. Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds. J Pharm Pharm Sci. 2001; 4 (3): 217-27.
- Gao K, Henning SM, Niu Y, Youssefian AA. The citrus flavonoid naringenin stimulates DNA repair in prostate cancer cells. J NutrBiochem. 2006; 17 (2): 1789-95.
- Su LanHsiu, TangYenHuang, Yu ChiHou, Der-Hang Chin, Pei Dawn LeeChao. Comparison of metabolic pharmacokinetics of naringin and naringenin in rabbits. J Life Sciences. 2002; 70(13): 1481-9.
- Jeon SM, Bok SH, Jang MK, Lee MK, Nam KT, Park YB, et al. Antioxidative activity of naringin and lovastatin in high cholesterol-fed rabbits. Life Sci. 2001; 69 (24): 2855-66.
- Fuhr U, Kummert AL. The fate of naringin in humans: a key to grapefruit juice-drug interactions?.ClinPharmacolTher. 1995;58:365-73.
- Ishii K, Furuta T, Kasuya Y. Determination of naringin and naringenin in human urine by high-performance liquid chromatography utilizing solid-phase extraction. J Chromatogr B Biomed SciAppl. 1997;704 (1-2): 299-305.
- Lee YS, Reidenberg MM. A method for measuring naringenin in biological fluids and its disposition from grapefruit juice by man. Pharmacology.1998; 56 (6): 314-7.
- FuhrU, and Kummert AL. The Fate of Naringin in Humans: A Key to Grapefruit Juice-Drug Interactions?.ClinPharmacolTher. 1995; 58 (4): 365-73.
- Trombetta D, Cimino F, Cristani M, Mandalari G, Saija A, Ginestra G, et al. In vitro protective effects of two extracts from bergamot peels on human endothelial cells exposed to tumor necrosis factor-a (TNF-a). J Agric Food Chem. 2010;58: 8430-6.
- ZdenkaCvetni, Sanda Vladimir-Kne. Antimicrobial activity of grapefruit seed and pulp ethanolic extract Acta Pharm.2004; (54): 243-50.
- Choi, MS. Effect of Naringin Supplementation on Cholesterol Metabolism and Antioxidant Status in Rats Fed High Cholesterol with Different Levels of Vitamin E. Ann NutrMetab.2001; 45 (5): 193-01.
- Gordon PB, Holen I, Seglen PO. Department of Tissue Culture, Norwegian Radium Hospital, Montebello, Oslo. J BiolChem. 1995;270: 5830-38.
- UweFuhr, kristinaklittich a. Horst staib. Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man. Br. J. Clin. Pharmac. 1993; 35(4): 431-6.
- Bailey DG, Dresser GK, Leake BF, Kim RB. Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice. ClinPharmacolTher. 2007;81 :495-2.
- Dresser GK, Bailey D, Leake B, Schwarz U, Dawson P, Freeman D, et al. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. ClinPharmacolTher. 2002;71:11-20.
- Ueng YF, Chang YL, Oda Y, Park SS, Liao JF, Lin MF. In vitro and in vivo effects of naringin on cytochrome P450-dependent monooxygenase in mouse liver. Life Sci.1999; 65 (24) 2591-602.
- PuP, Gao DM, Mohamed S, Chen J, Zhang J, Zhou XY, et al. Naringin ameliorates metabolic syndrome by activating AMP-activated protein kinase in mice fed a high-fat diet. Arch BiochemBiophys. 2012; 518 (1) 61-70.
- Li WL, Zheng HC, Bukuru J, De Kimpe N. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol. 2004; 92 (1): 1-4.
- Cho KW, Kim YO, Andrade JE, BurgessJR, Kim YC. Dietary naringenin increases hepatic peroxisome proliferators-activated receptor alpha protein expression and decreases plasma triglyceride and adiposity in rats. Eur J Nutr. 2001;50 (2): 81-8.
- Da Silva RR. Hypocholesterolemic Effect of Naringin and Rutin Flavonoids. Arch LatinoamNutr.2001; 51 (3): 258-64.
- Kanno S. Effects of naringin on hydrogen peroxide-induced cytotoxicity and apoptosis in P388 cells. J Pharmacol Sci. 2003; 92(2):166-70.
- Lee SH, Park YB, Bae KH, Bok SH, Kwon YK, Lee ES, et al. Cholesterol-lowering activity of naringenin via inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl coenzyme A:cholesterol acyltransferase in rats. Ann NutrMetab. 1999; 43 (3): 173-80.
- Yang Xiao, LaiLai Li, Yan Yan Wang, Jing JingGuo, Wen-Ping Xu, Yan Yan Wang, et al. Naringin administration inhibits platelet aggregation and release by reducing blood cholesterol levels and the cytosolic free calcium concentration in hyperlipidemic rabbits. Experimental And Therapeutic Medicine. 2014; 8: 968.
- Naderi GA, Asgary S, Sarraf-Zadegan N, Shirvany H Anti-oxidant effect of flavonoids on the susceptibility of LDL oxidation. Mol Cell Biochem. 2003; 246 (1-2): 193-6.
- Da Silva RR, de Oliveira TT, Nagem TJ, Pinto AS, Albino LF, de Almeida MR, et al. Hypocholesterolemic effect of naringin and rutin flavonoids. Arch LatinoamNutr. 2001; 51 (3): 258-64
- Shin YW, Bok SH, Jeong TS, Bae KH, Jeoung NH, Choi MS, et al. Korea Hypocholesterolemic effect of naringin associated with hepatic cholesterol regulating enzyme changes in rats. Int J VitamNutr Res. 1999; 69 (5): 341-7.
- Alam MA, Kauter K, Brown L, Naringin improves diet-induced cardiovascular dysfunction and obesity in high carbohydrate, high-fat diet fed rats. Nutrients.2013; 5 (3): 637-50.
- Ikemura M, Sasaki Y, Giddings JC, Yamamoto J. Preventive effects of hesperidin, glucosyl hesperidin and naringin on hypertension and cerebral thrombosis in stroke-prone spontaneously hypertensive rats. Phytother Res.2012; 26 (9): 1272-7.
- Fallahi F, Roghani M, Moghadami S. Citrus flavonoid naringenin improves aortic reactivity in streptozotocin-diabetic rats. Indian J Pharmacol. 2012; 44: 382-6.
- ShelaGorinstein, Hanna Leontowicz, MariaLeontowicz, RyszardKrzeminski, MikolajGralak, Efren Delgado-Licon, et al. Changes in Plasma Lipid and Antioxidant Activity in Rats as a Result of Naringin and Red Grapefruit Supplementation. J Agric. Food Chem. 2005; 53(8): 3223-8.
- Jung UJ. Naringin supplementation lowers plasma lipids and enhances erythrocyte antioxidant enzyme activities in hypercholesterolemic subjects. ClinNutr. 2003; 22 (6): 561-8.
- Kim HJ. Naringin alters the cholesterol biosynthesis and antioxidant enzyme activities in LDL receptor-knockout mice under cholesterol-fed condition. Life Sci. 2004; 74(3) : 1621-34.
- Kumar MS, Unnikrishnan MK, Patra S, Murthy K, Srinivasan KK, Antioxidant properties / ROS, Naringin, and naringenin inhibit nitrite-induced methemoglobin formation. Pharmazie.2003; 58 (8): 564-6.
- Jeon SM, Bok SH, Jang MK, Kim YH, Nam KT, Jeong TS, et al. Comparison of antioxidant effects of naringin and probucol in cholesterol-fed rabbits. ClinChimActa. 2002; 317 :181.
- Felicia V So, Najla Guthrie, Ann F Chambers, Madeleine Moussa, Kenneth K Carroll. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices, J nutrition and cancer.1996;26(2):167-81.
- Duarte N, Lage H, Abrantes M & Ferreira MJ, Phenolic compounds as selective antineoplasic agents against multidrug-resistant human cancer cells. PlantaMedica. 2010; 76(10): 975-80.
- Jonathan Goldwasser, Pazit Y, Cohen, Eric Yang, Patrick Balaguer, Martin L.et al. Transcriptional Regulation of Human and Rat Hepatic Lipid Metabolism by the Grapefruit Flavonoid Naringenin: Role of PPARa, PPARc, and LXRa. PLoS One. 2010; 5(8): 1-9 48. Chen YC, Shen SC, Lin HY. Rutinoside at C7 attenuates the apoptosis-inducing activity of flavonoids. BiochemPharmacol. 2003; 66 (7):1139-50.
- Bear WL, Teel RW, Effects of citrus phytochemicals on the liver and lung cytochrome P450 activity and on the in vitro metabolism of the tobacco-specific nitrosamine NNK. Anticancer Res 2000; 20 (5A) 3323-9.
- Francis AR, Shetty TK, Bhattacharya RK. Modulating effect of plant flavonoids on the mutagenicity of N-methyl-N'-nitro-N-nitrosoguanidine. Carcinogenesis.1989; 10 (10): 1953-5.
- Goldwasser J, Cohen PY, Lin W, Kitsberg D, Balaguer P, Polyak SJ, et al. Naringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPAR-mediated mechanism. J Hepatol.2011; 55( 5): 963-1.
- Hamalainen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappa B activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappa B activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm.2007 ; 2007: 456-73.
- Maria Luisa Balestrieri, DomenicoCastaldo, CiroBalestrieri, LucioQuagliuolo, Alfonso Giovane, Luigi Servillo. Modulation by flavonoids of PAF and related phospholipids in endothelial cells during oxidative stress. Journal of Lipid Research.2003; 44:380.
- Horiba T, Nishimura I, Nakai Y, Abe K, Sato R. Naringenin-chalcone improves adipocyte functions by enhancing adiponectin production. Mol Cell Endocrinol. 2010; 323 (2): 208-14.
- Hirai S, Kim, II Y, Goto T, Kang M-S, Yoshimura M, et al. Inhibitory effect of naringenin chalcone on inflammatory changes in the interaction between adipocytes and macrophages. Life Sci.2007; 81 (16): 1272-9.
- Paredes A, Alzuru M, Mendez J, Rodríguez-Ortega M. Anti-Sindbis activity of flavanoneshesperetin and naringenin. Biol Pharm Bull.2003; 26 (1): 108-9.
- Seo HJ, Jeong KS, Lee MK, Park YB, Jung UJ, Kim HJ. Role of naringin supplement in the regulation of lipid and ethanol metabolism in rats. Life Sci. 2003; 73 (7): 933-46.
- Robbins RC, Martin FG, Roe JM. Ingestion of grapefruit lowers elevated hematocrits in human subjects. Int J VitamNutr Res. 1988; 58 (4): 414-7.
- Zhang H, Wong CW, Coville PF, Wanwimolruk S. Effect of the grapefruit flavonoid naringin on the pharmacokinetics of quinine in rats. Drug Metabol Drug Interact.2000; 17 (1-4): 351-63
- Martin MJ, Marhuenda E, Perez-Guerrero C, Franco JM. Antiulcer effect of naringin on gastric lesions induced by ethanol in rats. Pharmacology. 1994; 49 (3): 144-50.
- Seo HJ, Jeong KS, Lee MK, Park YB, Jung UJ, Kim HJ. Role of naringin supplement in the regulation of lipid and ethanol metabolism in rats. Life Sci. 2003; 73 (7): 933-46.
- 6Robbins RC, Martin FG, Roe JM. Ingestion of grapefruit lowers elevated hematocrits in human subjects. Int J VitamNutr Res. 1988; 58 (4): 414-7.
- Zhang H, Wong CW, Coville PF, Wanwimolruk S. Effect of the grapefruit flavonoid naringin on the pharmacokinetics of quinine in rats. Drug Metabol Drug Interact.2000; 17 (1-4): 351-63
- Martin MJ, Marhuenda E, Perez-Guerrero C, Franco JM. Antiulcer effect of naringin on gastric lesions induced by ethanol in rats. Pharmacology. 1994; 49 (3): 144-50.
- Martín MJ. Antiulcer effect of naringin on gastric lesions induced by ethanol in rats. Pharmacology.1994; 49(3): 144-150.
- Parmar NS. The gastric anti-ulcer activity of naringenin, a specific histidine decarboxylase inhibitor. Int J Tissue React. 1983; 5 (4): 415-20.
- Choe SC, Kim HS, Jeong TS, Bok SH, Park YB. Naringin has an antiatherogenic effect with the inhibition of intercellular adhesion molecule-1 in hypercholesterolemic rabbits. J CardiovascPharmacol. 2001; 38 (6): 947-55.
- Choi MS, Do KM, Park YS, Jeon SM, Jeong TS, Lee YK, et al. Effect of naringin supplementation on cholesterol metabolism and antioxidant status in rats fed high cholesterol with different levels of vitamin E. Ann NutrMetab. 2001; 45 (5): 193-201.
- Lee CH, Jeong TS, Choi YK, Hyun BH, Oh GT, Kim EH, et al. Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits. BiochemBiophysRes Commun.2001; 284 (3): 681-8.
- Jagetia GC, Reddy TK. The grapefruit flavanone naringin protects against the radiation-induced genomic instability in the mice bone marrow: a micronucleus study. Mutat Res. 2002; 519 (1-2): 37-48.
- S.R. Suseem, Dhanish Joseph. Does A Contraindication Yield Therapeutic Activity?. Research J. Pharm. and Tech 2016; 9(11):2048-52.
- J Ramamoorthy, S Venkataraman, R Meera, N Chidambaranathan, P Devi Devisree. Phyto-Physico Chemical Investigation, Anti-inflammatory and Antimicrobial Activities of Pollianthestuberosa Linn. Research J. Pharm. and Tech.2009;2 (4): 738-2.
- Kasthuri KT, Radha R, N Jayshree, Anoop Austin, P Thirugnanasambantham. Standardization and In Vitro Anti Inflammatory Studies of A Poly Herbal Oil Formulation – Megni. Research J. Pharm. and Tech.2010; 3 (3): 792-94.
- Aejaz Ahmed, Sameer S. Sheaikh, Aijaz A. Sheikh. In Vivo Efficacy Study of Aceclofenac Gel Containing Linseed Oil and Ginger Oleoresin. Research J. Pharm. and Tech.2011; 4(6): 979-81.
- Mary Sebastian, Suresh J., Mruthunjaya K., A. Sri Vasavi Reddy ,Apurva Singh. An Overview of Pharmacognostical and Pharmacological Properties of Sidarhombifolia. Research J. Pharmacognosy and Phytochemistry 2012; 4(1): 49-52.
- DhanyaRajan, J. Suresh, N. Paramakrishnan, A. Sri Vasavi Reddy, M Nayeem . Review on Phytochemical and Pharmacological properties of Vitextrifolialinn. Research J. Pharmacognosy and Phytochemistry 2012; 4(2): 124-29.
- T. M. SreeVidhya, Geetha. In Vitro Evaluation of Anti-Inflammatory Activity of Andrographispaniculata. Research J. Pharm. and Tech. 2018; 11(3): 957-58.
- Ram Kumar Sahu, DevendraDewangan, Amit Roy, K. P. Namdev. Anti-inflammatory Action of Ougeiniaoojeinensis (Roxb.) Hochr. Bark by HRBC Membrane Stabilization. Research J. Pharm. and Tech. 2008; 1(1): 57-58.
- VH Bhaskar, B Sangameswaran, N Balakrishnan, AB Panda, Navin R Raj, ASathish. Screening of Analgesic and Anti-inflammatory Activity of Hydroalcohol Extract of Sida (Indian) Species Root. Research J. Pharm. and Tech.2008; 1(3): 287-89.
- B Sangameswaran, BR Balakrishnan, Y Malyadri, M Kumar, N Balakrishnan, B Jayakar. Anti-hyperlipidaemic Effect of Thespesia Lampas Dalz and Gibs on Triton Induced Rats. Research J. Pharm. and Tech. 2008; 1(4): 533-34.
- SrikanthJeyabalan, MuralidharanPalayan. Antihyperlipidemic activity of Sapindusemarginatus in Triton WR-1339 induced albino rats. Research J. Pharm. and Tech.2009; 2 (2):319-23.
- BK Gidwani, SushilBhargava, SP Rao, AMajoomdar, DP Pawar, RN Alaspure. Analgesic, Anti–Inflammatory and Anti–Hemorrhoidal Activity of Aqueous Extract of Lantana Camara Linn. Research J. Pharm. and Tech.2009 2(2): 378-81.
- SG Killedar, HN More. Analgesic and Anti-Inflammatory Studies of MemecylonumbellatumBurm Roots in Experimental Animals. Research J. Pharm. and Tech.2009; 2 (4):858-61.
- Vikas Gupta, ParveenBansal, Pawan Kumar, GurpreetKaur. Anti-Inflammatory and Anti-Nociceptive Activity of Adiantumcapillus. Research J. Pharm. and Tech. 2010; 3(2): 432-34.
- Charde RM, Charde MS, Fulzele SV, Satturwar PM, Kasture AV, Joshi SB. Evaluation of Ethanolic Extract of MoringaOleifera for Wound Healing, Anti-inflammatory and Antioxidant Activities on Rats. Research J. Pharm. and Tech. 2011; 4(2): 254-58.
- V. Manju, R. Revathi, M. Murugesan. In vitro Antioxidant, Antimicrobial, Anti-inflammatory, Anthelmintic Activity and Phytochemical Analysis of Indian Medicinal Spices. Research J. Pharm. and Tech. 2011; 4(4): 596-99.
- Applications of Magnetically Modulated Systems
Abstract Views :181 |
PDF Views:0
Authors
Dhanish Joseph
1,
Maria Jose
1
Affiliations
1 Nirmala College of Pharmacy, Department of Pharmaceutics, Muvattupuzha, Kerala, IN
1 Nirmala College of Pharmacy, Department of Pharmaceutics, Muvattupuzha, Kerala, IN
Source
Research Journal of Pharmacy and Technology, Vol 12, No 3 (2019), Pagination: 1391-1396Abstract
Magnetically modulated system is a promising targeted drug delivery approach which uses an external magnetic field to control the delivery of drug at a specific site avoiding other cellular toxicities. These magnetic particles have the ability to accumulate at a desired site by the guidance of an external magnetic field. So, magnetically modulated materials can be used for diagnostic and targeted drug delivery approaches. This review describes about various applications of magnetically modulated system. Magnetic nanoparticles can be used in a wide variety of applications ranging from contrast agents for magnetic resonance imaging to the destruction of cancer cells via hyperthermia treatment and targeted therapy. Superparamagnetic nanoparticles are promising candidates for gene delivery. The immobilization of enzymes on magnetic nanoparticles helps to increase the enzyme activity and stability which enhances their applicability in bioreactors and biosensors. Magnetically responsive microspheres can be used in bio-separation techniques to remove cells and molecules. Magnetic bead-based immunoassay can be applied to bio-molecule detection and analysis systems. Magnetic polymeric microspheres have the capacity to bind biological molecules which helps to separate RBC from the whole blood. Magnetic arterial embolization hyperthermia can target liver cancers through duel effects of local hyperthermia and arterial embolization. Magnetic nanoparticles is also a good tool for the treatment of water polluted with metal and organic materials.Keywords
Magnetite, Superparamagnetic Iron Oxide Nanoparticles, Magnetic Targeting, Nanomagnetosols, Magnetic Resonance Imaging.References
- Enriquez G, Rizvi SA, D’Souza MJ, Do DP et al. Formulation and evaluation of drug-loaded targeted magnetic microspheres for cancer therapy. International Journal of Nanomedicine. 2013; 8:1393-02.
- Naqvi S, Samim M, Dinda AK et al. Impact of magnetic nanoparticles in biomedical applications. Recent Patents on Drug Delivery and Formulation. 2009; 3(2):153-61.
- Barakat NS. Magnetically modulated nanosystems: a unique drug delivery platform. Nanomedicine. 2009; 4(7).
- Alexiou C, Tietze R, Schreiber E et al. Cancer therapy with drug loaded magnetic nanoparticles-magnetic drug targeting. Journal of Magnetism Magnetic Mater. 2011; 1404-07.
- Liang PC, Chen YC, Chiang CF et al. Doxorubicin-modified magnetic nanoparticles as a drug delivery system for magnetic resonance imaging-monitoring magnet-enhancing tumor chemotherapy. International Journal of Nanomedicine. 2016; 11; 2021–37.
- SabnisS, Sabnis NA, Raut S et al. Superparamagnetic reconstituted high-density lipoprotein nanocarriers for magnetically guided drug delivery. International Journal of Nanomedicine. 2017;12: 1453–64.
- Eguchi H, Umemura M, Kurotani R et al. A magnetic anti-cancer compound for magnet-guided delivery and magnetic resonance imaging. Scientific Reports. 2015; 5: 1-14.
- Shi C, Thum C, Zhang Qet al. Inhibition of the cancer-associated TASK 3 channels by magnetically induced thermal release of Tetrandrine from a polymeric drug carrier. Journal of Controlled Release. 2016; 237: 50-60.
- Vinod KR, Sridhar D, Sandhya S, Banji D, Reddy TR. Essentials of Pharmaceutical Product Development for Magnetically Modulated Drug Delivery Systems, A review. International Journal of Pharmaceutical Sciences and Nanotechnology. 2012; 4(4):1519-27.
- Gkanas EI. In vitro magnetic hyperthermic response of iron oxide MNP’s incorporated in DA3, MCF-7 and HeLa cancer cell lines. Central European Journal of Chemistry. 2013; 11(7): 1042-54.
- Sanchez J, Cortes-Hernandez DA, Jasso-Terran RA et al. Bioactive magnetic nanoparticles of Fe-Ga synthesized by sol-gel for their potential use in hyperthermia treatment. Journal of Materials Science: Materials in Medicine. 2014; 25: 2237-42.
- Kawashita M, Li Z, Hiraoka M. Preparation of Size-Controlled Magnetite Nanoparticles for Hyperthermia of Cancer. Transaction of the Materials Research Society of Japan. 2009; 34[1]: 77-80.
- Huang HS, Hainfeld JF. Intravenous magnetic nanoparticle cancer hyperthermia. International Journal of Nanomedicine. 2013; 3(8): 2521-32.
- Sivakumar B, Aswathy RG, Sreejith R et al. Bacterial exopolysaccharide based magnetic nanoparticles: a versatile nanotool for cancer cell imaging, targeted drug delivery and synergistic effect of drug and hyperthermia mediated cancer therapy. Journal of Biomedical Nanotechnology. 2014; 10(6): 885-99.
- Matsuoka F, Shinkai M, Honda H et al. Hyperthermia using magnetite cationic liposomes for hamster osteosarcoma. Bio Magnetic Research and Technology. 2004; 2(1): 3.
- Balasubramanian S, Girija AR, Nagaoka Y et al. Curcumin and 5-fluorouracil-loaded, folate- and transferrin-decorated polymeric magnetic nanoformulation: a synergistic cancer therapeutic approach, accelerated by magnetic hyperthermia. International Journal of Nanomedicine. 2014; 9(1): 437-59.
- Wang J, Chen Y, Chen B et al. Pharmacokinetic parameters and tissue distribution of magnetic iron oxide nanoparticles in mice. International Journal of Nanomedicine. 2010; 5: 861–66.
- Kong SD, Lee J, Ramachandran S et al. Magnetic targeting of nanoparticles across the blood brain barrier. Journal of Control Release. 2012; 164(1): 49-57.
- Saiyed Z, Gandhi N, Nair MPN. Magnetic nanoformulation of azidothymidine 5’-triphosphate for targeted delivery across the blood brain barrier. International Journal of Nanomedicine. 2010; 5: 157-66.
- Ding H, Sagar V, Agudelo M et al. Enhanced blood brain barrier transmigration using a novel transferrin embedded fluorescent magneto-liposome nanoformulation. Nanotechnology. 2014; 25(5): 055101.
- Mu K, Zhang S, Ai T et al. Monoclonal antibody-conjugated superparamagnetic iron oxide nanoparticles for imaging of epidermal growth factor receptor- targeted cells and gliomas. Molecular Imaging. 2015; 14(4): 2-12.
- Chertok B, David AE, Yang VC et al. Brain tumor targeting of magnetic nanoparticles for potential drug delivery: Effect of administration route and magnetic field topography. Journal of Control Release. 2011; 155(3): 393- 99.
- Dames P, Gleich B, Flemmer AW, Rudolph C. Targeted delivery of magnetic aerosol droplets to the lungs. Nature Nanotech. 2007; 2(8): 1-5.
- Sanna V, Singh CK, Jashari R et al. Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapy. Science Reports. 2017: 1-15.
- Li C, Li L, Keates AC. Targeting cancer gene therapy with magnetic nanoparticles. Oncotarget. 2012; 3: 365-70.
- Uthaman S, Lee ST, Cherukula K et al. Polysaccharide-coated magnetic nanoparticles for imaging and gene therapy. BioMed Research International. 2015: 1-14.
- Wang Y, Cui H, Li K et al. A magnetic nanoparticle-based multiple gene delivery system for transfection of porcine kidney cells. Plos one. 2014; 9(7): 1-9.
- Tang Y, Wang D, Zhang S. Bacterial magnetic particles as a novel and efficient gene vaccine delivery system. Gene Therapy. 2012; 19: 1187-95.
- Przybylski S, Gasch M, Marschner Aet al. Influence of nanoparticle-mediated transfection on proliferation of primary immune cells in vitro and in vivo. Plos one. 2017: 1-16.
- Davaran S, Akbarzadeh A, Nejati-Koshki K et al. In vitro studies of NIPAAM-MAA-VP copolymer coated magnetic nanoparticles for controlled anticancer drug release. 2013; 3: 108-15.
- Ebrahimnezhad Z, Zarghami N, Keyhani M et al. Inhibition of hTERT gene expression by silibinin-loaded PLGA-PEG-Fe3O4 in T47D breast cancer cell line. Bioimpacts. 2013; 3(2): 67-74.
- Das M, Wang C, Bedi R et al. Magnetic micelles for DNA delivery to rat brains after mild traumatic brain injury. Nanomedicine. 2014; 10(7): 1539-48.
- Ghosh S, Ahmad R, Gautam VK, Khare SK et al. Cholesterol-oxidase-magnetic nanobioconjugates for the production of 4-cholesten-3-one and 4-cholesten-3, 7-dione. Bioresource Technology. 2018; 254: 91–96.
- Xiao A, Xua C, Lin Y, Ni H et al. Preparation and characterization of κ-carrageenase immobilized onto magnetic iron oxide nanoparticles. Electronic Journal of Biotechnology. 2016; 19: 1–7.
- Xiao A, Xiao Q, Lin Y et al. Efficient immobilization of agarase using carboxyl-functionalized magnetic nanoparticles as support. Electronic Journal of Biotechnology. 2017; 25: 13-20.
- Liao MH, Chen DH. Immobilization of yeast alcohol dehydrogenase on magnetic nanoparticle for improving its stability. Biotechnology Letters. 2001; 23(20): 1723-27.
- Huang SH, Liao MH, Chen DH. Direct binding and characterization of lipase on to magnetic nanoparticles. Biotechnology Progress. 2003; 19 (3): 1095-100.
- Choi JW, Kwang W, Jennifer H et al. An integrated microfluidic biochemical detection system for protein analysis with magnetic bead based sampling capabilities. Royal Society of Chemistry. 2002; 2:27-37.
- Petrakova AV, Urusov AE, Zherdev AV et al. Application of magnetic nanoparticles for the development of highly sensitive immunochromatographic test systems for mycotoxin detection. Applications of Biochemistry and Microbiology. 2017; 53: 420-26.
- Chen Y, Xianyu Y, Wang Y et al. One-Step Detection of Pathogens and Viruses: Combining Magnetic Relaxation Switching and Magnetic Separation. ACS Nano. 2015; 9 (3):3184–91.
- Bhalla N, Chung WYD, Wang K et al. Electrowetting enabled magnetic particle immunoassay with on-chip magnetic washing. IEEE Sensors. 2013.
- Bhalla N, Chung DWY, Chang YJ et al. Microfluidic platform for enzyme-linked and magnetic particle-based immunoassay. Micromachines. 2013; 4: 257-71.
- Kongsuphol P, Liu Y, Ramadan Q. On-chip immune cell activation and subsequent time-resolved magnetic bead-based cytokine detection. Biomedical Microdevices. 2016; 18(5): 93.
- Bruls DM, Evers TH, Kahlman JA et al. Rapid integrated biosensor for multiplexed immunoassays based on actuated magnetic nanoparticles. Lab Chip. 2009; 9(24): 3504-10.
- Dittmer WU, De Kievit P, Prins MW et al. Sensitive and rapid immunoassay for parathyroid hormone using magnetic particle labels and magnetic actuation. Journal of Immunological Methods. 2008; 338(1-2): 40-46.
- Aytur T, Foley J, Anwar M et al. A novel magnetic bead bioassay platform using a microchip-based sensor for infectious disease diagnosis. Journal of Immunological Methods. 2006; 314(1-2): 21-29.
- Svobodova Z, Jankovicova B, Krulisova P et al. On-chip ELISA on magnetic particles: isolation and detection of specific antibodies from serum. Nanocon. 2015: 1-6.
- Chattopadhyay D, Sarkar K. Purification of quality DNA from citrus plant using iron oxide nanoparticles as solid support. Journal of Plant Development Sciences. 2018; 10(3): 149-56.
- Shi R, Wang Y, Hu Y et al. Preparation of magnetite-loaded silica microspheres for solid-phase extraction of genomic DNA from soy-based foodstuffs. Journal of Chromatography. 2009; 1216: 6382-86.
- Felinto MC, Parra DF, Lugao AB et al. Magnetic polymeric microspheres for protein adsorption. Nuclear Instruments and Methods in Physics Research Section B: Beam Interaction with Materials and Atoms. 2005; 236: 495-500.
- Chatterjee J, Chen CJ. Modification and characterization of polystyrene-based magnetic microspheres and comparison with albumin-based magnetic microspheres. 2001; 225(1-2): 21-29.
- Shen CR, Wu ST, Tsai ZT et al. Characterization of a quaternized chitosan imaging contrast agent for cell tracking. Polymer International. 2011; 60(6): 945-50.
- Tsai ZT, Tsai FU, Yang WC et al. Preparation and characterization of ferrofluid stabilized with biocompatible chitosan and dextran sulfate hybrid biopolymer as a potential magnetic resonance imaging T2 contrast agent. Marine Drugs. 2012; 10(11): 2403-14.
- Wang H, Fan TY. Preparation and evaluation of MRI detectable poly (acrylic acid) microspheres loaded with superparamagnetic iron oxide nanoparticles for trans catheter arterial embolization. International Journal of Pharmaceutics. 2016; 511(2): 831-39.
- Li Z, Kawashita M, Araki N et al. Magnetic SiO2 gel microspheres for arterial embolization hyperthermia. Biomedical Materials. 2010; 5.
- Li D, Wang K, Wang X et al. Magnetic arterial embolization hyperthermia mediated by carbonyl iron powder for liver carcinoma. World Congress Medicine Physics and Biomedical Engineering. 2012: 1624-27.
- Shomura Y, Tanigawa N, Shibutani M et al. Water soluble polyvinyl alcohol (PVA) microspheres for temporary embolization: development and in vivo characterization in a pig kidney model. Journal of Vascular and Interventional Radiology. 2011.
- Qiu S, Ge NJ, Sun DK et al. Synthesis and characterization of magnetic polyvinyl alcohol hydrogel microspheres for the embolization of blood vessels. Trans Biomed Eng. 2015; 63(4): 730-36.
- Gregorio-Jauregui KM, Pineda MG, Rivera-Salinas JE et al. One-Step Method for Preparation of Magnetic Nanoparticles Coated with Chitosan. Journal of Nanomaterials 60. Podzus PE, Daraio ME, Jacobo SE. Chitosan magnetic microspheres for technological applications: preparation and characterization. Physica B: Condensed Matter. 2009; 404(18): 2710-12.
- Reddy DH, Lee SM. Application of magnetic chitosan composites for the removal of toxic metal and dyes from aqueous solutions. Advanced Colloid Interface Science. 2013; 201-202: 68-93.
- Yin Y, Wang J, Yang X, Li W. Removal of Strontium Ions by Immobilized Saccharomyces Cerevisiae in Magnetic Chitosan Microspheres. Nuclear Engineering and Technology. 2017; 49(1): 172-77.
- Jain H, Panchal R, Pabla D et al. Magnetic Nanoparticles: As a Drug Targeting Carrier. Research Journal of Pharmacy and Technology. 2011; 4(7): 1040-45.
- Magdum SV, Patil SV, Patil SS. Magnetic Nanoparticles for Cancer Therapy. Asian Journal of Pharmacy and Technology. 2017; 7(4): 251-60.
- Jangde R. Magnetically Modulated Drug Delivery Systems: An Overview. Research Journal of Pharmacy and Technology. 2011; 4(11): 1649-57.
- Jaiswal R, Singh S, Pande H. Magnetic Nanoparticles Activated Carbon: Preparation, Characterization and Application: A Review article. Asian Journal of Research in Chemistry. 2015; 8(12): 457-768.
- Sonkamble SG, Tigote RM. Mild and Efficient Enamination of β-Dicarbonyl Compounds Catalyzed by Fe3O4 nanoparticles under Solvent-Free Conditions. Asian Journal of Research in Chemistry. 2014; 7(11): 899-904.
- Seenuvasan M, Balaji N, Kumar MA. Review on Enzyme Loaded Magnetic Nanoparticles. Asian Journal of Pharmacy and Technology. 2013; 3(4): 200-208.
- Ramya D, Varsha KR, Ranjitha V. Magnetic Nanoparticles as Versatile Carriers for Immobilization of Laccase. Research Journal of Engineering and Technology. 2013; 4(4): 279-283.
- Ramankannan A, Suganthi RG, Balaji N, Seenuvasan M. Preparation and Characterization of Pectinase bound Co-precipitated Magnetic Nanoparticles. Asian Journal of Pharmacy and Technology. 2013; 3(40: 175-180.
- A Review on Current Applications of Bilayer Tablets
Abstract Views :185 |
PDF Views:0
Authors
Affiliations
1 Nirmala College of Pharmacy Muvattupuzha, Ernakulam, Kerala, IN
1 Nirmala College of Pharmacy Muvattupuzha, Ernakulam, Kerala, IN
Source
Research Journal of Pharmacy and Technology, Vol 12, No 5 (2019), Pagination: 2539-2544Abstract
Bilayer tablet technology is an improved beneficial technology to overcome the shortcomings of the single-layered tablet. The introduction of bilayer tablets into the pharmaceutical industry has enabled the development of pre-determined release profiles of active ingredients and incorporation of incompatible active ingredients into a single unit dosage form. Bilayer tablets provide one of the important design approaches where incompatible drugs, with a different indication, and same drug with different release rate can be incorporated in a single unit. Bilayer tablet is suitable for sequential release of two drugs in combination, and for sustained release tablets in which one Layer is immediately released as initial dose and the second layer is a maintenance dose. Bilayer formulations carry one drug, and deliver each of them without any pharmacokinetic or dynamic interactions, with their individual rate of delivery. Controlled release dosage forms have been extensively used to improve therapy with several important drugs. Use of bilayer tablet is a very different aspect for anti-inflammatory and analgesic drugs. This review discusses various applications of bilayer tablets such as controlling of delivery rate, providing synergic property and agonistic effect, administration of fixed-dose combinations etc. In sustained release tablet formulations, the commonly used functional ingredient is HPMC and in immediate release, the commonly used functional ingredients are Sodium Starch Glycollate, Crospovidone, and Croscarmellose sodium.Keywords
Bilayer Tablet, Immediate Release, Sustained Release, Super Disintegrant, Release Pattern.References
- Shila V. Devtalu, Ashwini E. Patil1, Manoj M. Bari1, et al; A Review on Novel Approach – Bilayer Tablet Technology. International Journal of Pharmaceutical Sciences Review and Research. 2013; 21(1):46-52.
- Hemanth Kumar, K. Kavitha, Selvi Arun Kumar, et al; Novel approach of bilayer technology –A review. International Journal of Pharmaceutical, Chemical and Biological Sciences.2013; 3(3):887-893.
- Shila V. Devtalu, Ashwini E. Patil1, Manoj M. Bari1, et al; A Review on novel approach –Bilayer technology. International Journal of Pharmaceutical Sciences Review and Research. 2013; 21(1): 46-52.
- Verma Rameshwar, Devre Kishor, Gangrade Tushar, Bi-layer tablets for various drugs: A review, Scholars Academic Journal of Pharmacy. 2014; 3(3): 271-279.
- C. Gopinath, V. Hima Bindu, M. Nischala. An overview on bilayered tablet technology. Journal of Global Trends in Pharmaceutical Sciences. 2013; 4 (2): 1077-1085.
- Anupam Sachan N and Ankita Gupta. Formulation and Evaluation of Bilayer Tablets of Nitazoxanide. Der Pharmacia Lettre [http://scholarsresearchlibrary.com/archive.html]. 2017; 9[7]:1-9.
- S. Jayaprakash, S. Mohamed Halith, K. Kulathuran Pillai, et al; Formulation and evaluation of bilayer tablets of amlodipine besilate and metprolol succinate. Der Pharmacia Lettre(http://scholarsresearchlibrary.com/archive.html). 2011; 3 (4): 143-154
- Pamu. Sandhya, Faheem Unnisa Begum, Afreen. Formulation and Evaluation of Bilayer Tablets of Glimepiride and Metformin HCL. IOSR-Journal of Pharmacy and Biological Sciences.2014); 9(1) :38-45
- Dr. Vijaya Kuchana, Ayesha Farooqui, Peddireddy, et al; Development and characterization of bilayer tablets of candesartan cilexetil. Indo American Journal of Pharmacy. 2017; 3 (6): 338-346.
- Lokesh Kumar, M. Vijay Kumar and Gaurav Tiwari, Combinational therapy of Rosuvastatin calcium and Fenofibrate as bilayer tablet: A potential approach to control hypolipidemia. International Journal of Pharmaceutical Sciences and Research.2016; 7(1): 413-428.
- Navesh Veer, Lal Ratnakar Singh and Lalit Kumar Tyagi. Formulation and evaluation of bilayer sustain release tablet of Allopurinol and Telmisartan for the the treatment of hyperuricemia associated with hypertension. World Journal of Pharmacy and Pharmaceutical Sciences. 2018; 7(5): 1189-1209.
- Chinamniranjan Patra, Arethibharani Kumar, Hemant Kumarpandit, etal; Design and evaluation of sustained release bilayer tablets of propranolol hydrochloride. Acta Pharm. 57 (2007) 479–489.
- Metkar Vishal, Kumar Anuj, Pant Pankaj, etal; Formulation, development and evaluation of Bilayer tablets of Lornoxicam. International Journal of Drug Development & Research. 2012; 4 (2): 173-179.
- Momin Shahanoor, Khan Shadab, Ghadage D.M., Yadav et al; Formulation and evaluation of bilayer tablet of propranolol hydrochloride. Journal of Drug Delivery &Therapeutics. 2017; 7(2):50-57.
- Rajeev Sharma, Naresh Kalra, Rahul Gupta etal; Development and evaluation of sustained release bilayer matrix tablet of glipizide and metformin hydrochloride. International Journal of Drug Research and Technology.2014; 4 (1):01-13
- Surendra G. Gattani, Sohan S. Khabiya, Jitendra R. Amrutkar. Formulation and Evaluation of Bilayer Tablets of Metoclopramide Hydrochloride and DiclofenacSodium.PDA Journal of pharmaceutical science and technology.2012; 66(2):151-160.
- R. P. Swain, Shilpa Pendela and S. Panda. Formulation and evaluation of gastro bilayer floating tablets of simvastatin as immediate release layer and atenolol as sustained release layer. Indian Journal of pharmaceutical sciences. 2016; 78(4):458-468
- Nawar M. Toma and YehiaI. Khalil. Formulation and Evaluation of Bilayer Tablets Containing Immediate Release Aspirin Layer and Floating Clopidogrel Layer. Iraqi Journal of pharmaceutical sciences.2013; 22(1): 40-49.
- P.H. Wakde, R.H. Kasliwal and S.B. Mane. Design and fabrication of gastro retentive bilayer floating tablet of propronolol Hcl using natural. International Journal of Pharmaceutical Sciences and Research. 2013; 4(12): 123-136.
- GV. Wadageri, SA. Raju, SB. Shirsand, et al; Development and Evaluation of Mucoadhesive Bilayer Buccal Tablets of Carvedilol. International Journal of Research in Pharmaceutical and Biomedical Sciences. 2012; 3 (2): 576-584.
- Shiv Kumar, Lal Ratnakar Singh and Lalit Kumar Tyagi. Formulation and evaluation of bilayer floating tablet of levocetirizine and Terbutaline. World journal of pharmacy and pharmaceutical sciences.2018; 7(5): 1210-1228.
- Soham Shukla, Vikram Pandya, Praful Bhardiaetal. Bi-layer Tablet system – An Innovative trend. Asian Journal of Pharmaceutical Research.2013; 3(4):49-56.
- J. Ravi Kumar Reddy, Y. Indira Muzib, K. P. R. Chowdary. Development and Characterization of Novel Trans Buccoadhesive Bilayer Tablets of Tapentadol Hydrochloride. Research Journal of Pharmaceutical Dosage forms and Technology.2013; 3(2):83-89.
- P. Purushothaman, A. Umar Faruk Sha, T. Vetrichelvan. Formulation development and Evaluation of immediate and sustained release Bilayer Tablets Containing Amitriptyline HCl and Pregabalin for the treatment of Neuropathic Pain. Research Journal of Pharmaceutical Dosage forms and Technology.2017; 7(3):127-136.
- Svapnil Sanghavi, Misam Polara, Manish Patel. Bilayer Tablets – A Review of State of Art. Research Journal of Pharmaceutical Dosage forms and Technology.2012; 4(3):160-165.
- Soham Shukla, Vikram Pandya, Praful Bhardia etal. Formulation and In vitro Evaluation of Immediate Release Bilayer Tablets of Telmisartan and Amlodipine Besylate. A Review of State of Art. Research Journal of Pharmaceutical Dosage forms and Technology.2013; 5(2):79-87.
- Nishanth I., Elango K., Deattu N. Stephen P. Formulation Development and Evaluation of Bilayer Tablets of Telmisartan for Immediate Release and Metformin Hydrochloride for Sustained Release. Research Journal of Pharmaceutical Dosage forms and Technology.2013; 5(3):139-144.
- Hamid Khan, Mushir Ali, Alka Ahuja. Formulation and In-Vitro Evaluation of In-lay Matrix Tablets Containing Telmisartan and Hydrochlorothiazide. Research Journal of Pharmaceutical Dosage forms and Technology. 2015; 7(3):193-198.
- Hamid Khan, Javed Ali. Formulation and Evaluation of Sustained Release Matrix Tablets Containing Aceclofenac and Paracetamol. Research Journal of Pharmaceutical Dosage forms and Technology.2017; 9(2):48-52.
- Salma Banu S.K. and Venkateswara Rao T. Design and Development of Sustained Release Bilayered Tablets of Glipizide. Research Journal of Pharmaceutical Dosage forms and Technology.2012; 4(1):24-31.
- Prakash N Kendre, Syed N Lateef, Rahul K Godge et al. Formulation and in vitro-in vivo Evaluation of Theophyline and Salbutamol Sulphate Sustained Release Tablets. Research Journal of Pharmaceutical Dosage Forms and Technology.2009; 1(2):103-107